How many studies have been conducted on Galantamine?

BiohacksAI has indexed 297 PubMed studies on Galantamine, including 53 randomized controlled trials (RCTs). 54% of studies involve human subjects.

What are the main research areas for Galantamine?

The primary research domains for Galantamine are 🧠 Neuroprotection, 🧠 Cognitive, 🧠 Memory. This is based on analysis of 297 PubMed studies using the BiohacksAI evidence platform.

BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.

Galantamine

A benzazepine derived from norbelladine. It is found in GALANTHUS and other AMARYLLIDACEAE. It is a cholinesterase inhibitor that has been used to reverse the muscular effects of GALLAMINE TRIETHIODIDE and TUBOCURARINE and has been studied as a treatment for ALZHEIMER DISEASE and other central nervous system disorders.

297+ PubMed studies analyzed · 53 RCTs · Evidence Score: 52.3

Research Domains

Galantamine has been studied across 18 research domains including 🧠 Neuroprotection, 🧠 Cognitive, 🧠 Memory, 🧠 Focus & Attention, 🔬 Inflammation. The primary research focus is 🧠 Neuroprotection with 54% of studies addressing this area.

Loading evidence profile...

This evidence profile for Galantamine is generated deterministically from 297 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.